Ixazomib Citrate (MLN9708) Analogue [1201902-80-8]
S2181
Product group Chemicals
Overview
- SupplierSelleck Chemicals
- Product NameIxazomib Citrate (MLN9708) Analogue [1201902-80-8]
- Delivery Days Customer9
- CertificationResearch Use Only
- Scientific DescriptionIxazomib Citrate (MLN9708) Analogue is the analogue of Ixazomib Citrate (MLN9708) from WO2016165677A1. Ixazomib Citrate (MLN9708) immediately hydrolyzed to Ixazomib (MLN2238), the biologically active form, on exposure to aqueous solutions or plasma. Ixazomib (MLN2238) inhibits the chymotrypsin-like proteolytic (bèta5) site of the 20S proteasome with IC50/Ki of 3.4 nM/0.93 nM in cell-free assays, less potent to bèta1 and little activity to bèta2. Ixazomib (MLN2238) induces autophagy. Phase 3.
- UNSPSC12352200